1422 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Download search resultsDownload the search results for:
"Sexually Transmitted Diseases, Viral" (1422 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
2 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
5 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
6 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
7 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
8 Completed Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection
Condition: HIV Infection
Intervention: Drug: VM-1500/Placebo
9 Recruiting CPAP Improving Mortality for Pneumonia in African Children Trial
Conditions: Pneumonia;   Human Immunodeficiency Virus (HIV);   Malnutrition
Intervention: Device: bubble continuous positive airway pressure (CPAP)
10 Recruiting Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Condition: External Genital Warts
Interventions: Drug: LFX453;   Drug: Aldara®
11 Not yet recruiting First Event of Infection by HIV-1 of Uterine Vaginal Tissue
Condition: HIV Infection of the Uterine Vaginal Tissues
Intervention:
12 Active, not recruiting Randomized Controlled Trial of Shang Ring Children Circumcision: Comparison Between Flip and No Flip Technique
Condition: Human Immunodeficiency Virus
Interventions: Device: No flip technique of Shang Ring circumcision;   Device: Flip technique of Shang Ring circumcision
13 Not yet recruiting Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/GS-5816
14 Active, not recruiting Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection
Condition: Treatment of Hepatitis C
Intervention: Drug: Ledipasvir/Sofosbuvir FDC
15 Not yet recruiting Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Subjects do not receive study medication in this study 202094
16 Not yet recruiting Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir tablet 30 mg once daily for 28 days.;   Drug: Cabotegravir injection 400 mg/2mL (2 x 400 mg split injection) IM given once on Day 1.
17 Recruiting Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: Vorinostat;   Drug: Hydroxychloroquine;   Drug: Maraviroc;   Drug: Tenofovir;   Drug: Emtricitabine;   Drug: Efavirenz;   Drug: Darunavir
18 Not yet recruiting The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
Condition: HIV Infection
Interventions: Drug: Raltegravir 1200 mg;   Drug: TUMS;   Drug: MAALOX
19 Not yet recruiting VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
Condition: HIV
Intervention: Biological: VRC-HIVMAB060-00-AB (VRC01)
20 Not yet recruiting Acute Partner and Social Contact Referral: iKnow
Conditions: Acute HIV Infection;   HIV Seropositive;   Sexually Transmitted Infections
Intervention: Other: Notification cards

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years